1 Market Overview

1.1 Anti-Infective Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Anti-Infective Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Inactivated Vaccines

1.2.3 Conjugate Vaccines

1.2.4 Live/attenuated Vaccines

1.3 Market Analysis by Application

1.3.1 Overview: Global Anti-Infective Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Bacterial Diseases

1.3.3 Viral Diseases

1.4 Global Anti-Infective Vaccines Market Size & Forecast

1.4.1 Global Anti-Infective Vaccines Sales in Value (2016-2026))

1.4.2 Global Anti-Infective Vaccines Sales in Volume (2016-2026)

1.4.3 Global Anti-Infective Vaccines Price by Type (2016-2026) & (US$/Unit)

1.5 Global Anti-Infective Vaccines Production Capacity Analysis

1.5.1 Global Anti-Infective Vaccines Total Production Capacity (2016-2026)

1.5.2 Global Anti-Infective Vaccines Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Anti-Infective Vaccines Market Drivers

1.6.2 Anti-Infective Vaccines Market Restraints

1.6.3 Anti-Infective Vaccines Trends Analysis

2 Manufacturers Profiles

2.1 Emergent BioDefense Operations Lansing Inc.

2.1.1 Emergent BioDefense Operations Lansing Inc. Details

2.1.2 Emergent BioDefense Operations Lansing Inc. Major Business

2.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services

2.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Sanofi Pasteur

2.2.1 Sanofi Pasteur Details

2.2.2 Sanofi Pasteur Major Business

2.2.3 Sanofi Pasteur Anti-Infective Vaccines Product and Services

2.2.4 Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Merck & Co.

2.3.1 Merck & Co. Details

2.3.2 Merck & Co. Major Business

2.3.3 Merck & Co. Anti-Infective Vaccines Product and Services

2.3.4 Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 MedImmune LLC

2.4.1 MedImmune LLC Details

2.4.2 MedImmune LLC Major Business

2.4.3 MedImmune LLC Anti-Infective Vaccines Product and Services

2.4.4 MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Novartis Vaccines

2.5.1 Novartis Vaccines Details

2.5.2 Novartis Vaccines Major Business

2.5.3 Novartis Vaccines Anti-Infective Vaccines Product and Services

2.5.4 Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Diagnostics Ltd.

2.6.1 Diagnostics Ltd. Details

2.6.2 Diagnostics Ltd. Major Business

2.6.3 Diagnostics Ltd. Anti-Infective Vaccines Product and Services

2.6.4 Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Intercell Biomedical

2.7.1 Intercell Biomedical Details

2.7.2 Intercell Biomedical Major Business

2.7.3 Intercell Biomedical Anti-Infective Vaccines Product and Services

2.7.4 Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 MassBiologics

2.8.1 MassBiologics Details

2.8.2 MassBiologics Major Business

2.8.3 MassBiologics Anti-Infective Vaccines Product and Services

2.8.4 MassBiologics Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Barr Labs, Inc.

2.9.1 Barr Labs, Inc. Details

2.9.2 Barr Labs, Inc. Major Business

2.9.3 Barr Labs, Inc. Anti-Infective Vaccines Product and Services

2.9.4 Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Organon Teknika Co.

2.10.1 Organon Teknika Co. Details

2.10.2 Organon Teknika Co. Major Business

2.10.3 Organon Teknika Co. Anti-Infective Vaccines Product and Services

2.10.4 Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 GlaxoSmithKline Biologicals

2.11.1 GlaxoSmithKline Biologicals Details

2.11.2 GlaxoSmithKline Biologicals Major Business

2.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services

2.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 CSL Ltd.

2.12.1 CSL Ltd. Details

2.12.2 CSL Ltd. Major Business

2.12.3 CSL Ltd. Anti-Infective Vaccines Product and Services

2.12.4 CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 ID Biomedical Co.

2.13.1 ID Biomedical Co. Details

2.13.2 ID Biomedical Co. Major Business

2.13.3 ID Biomedical Co. Anti-Infective Vaccines Product and Services

2.13.4 ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Protein Sciences Co.

2.14.1 Protein Sciences Co. Details

2.14.2 Protein Sciences Co. Major Business

2.14.3 Protein Sciences Co. Anti-Infective Vaccines Product and Services

2.14.4 Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Wyeth Pharmaceuticals, Inc.

2.15.1 Wyeth Pharmaceuticals, Inc. Details

2.15.2 Wyeth Pharmaceuticals, Inc. Major Business

2.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services

2.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Berna Biotech

2.16.1 Berna Biotech Details

2.16.2 Berna Biotech Major Business

2.16.3 Berna Biotech Anti-Infective Vaccines Product and Services

2.16.4 Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Anti-Infective Vaccines Sales by Manufacturer

3.1 Global Anti-Infective Vaccines Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Anti-Infective Vaccines Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Anti-Infective Vaccines

3.4 Market Concentration Rate

3.4.1 Top 3 Anti-Infective Vaccines Manufacturer Market Share

3.4.2 Top 6 Anti-Infective Vaccines Manufacturer Market Share

3.5 Global Anti-Infective Vaccines Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Anti-Infective Vaccines Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Anti-Infective Vaccines Market Size by Region

4.1.1 Global Anti-Infective Vaccines Sales in Volume by Region (2016-2026)

4.1.2 Global Anti-Infective Vaccines Revenue by Region (2016-2026)

4.2 North America Anti-Infective Vaccines Revenue (2016-2026)

4.3 Europe Anti-Infective Vaccines Revenue (2016-2026)

4.4 Asia-Pacific Anti-Infective Vaccines Revenue (2016-2026)

4.5 South America Anti-Infective Vaccines Revenue (2016-2026)

4.6 Middle East and Africa Anti-Infective Vaccines Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Anti-Infective Vaccines Sales in Volume by Type (2016-2026)

5.2 Global Anti-Infective Vaccines Revenue by Type (2016-2026)

5.3 Global Anti-Infective Vaccines Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Anti-Infective Vaccines Sales in Volume by Application (2016-2026)

6.2 Global Anti-Infective Vaccines Revenue by Application (2016-2026)

6.3 Global Anti-Infective Vaccines Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Anti-Infective Vaccines Sales by Type (2016-2026)

7.2 North America Anti-Infective Vaccines Sales by Application (2016-2026)

7.3 North America Anti-Infective Vaccines Market Size by Country

7.3.1 North America Anti-Infective Vaccines Sales in Volume by Country (2016-2026)

7.3.2 North America Anti-Infective Vaccines Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Anti-Infective Vaccines Sales by Type (2016-2026)

8.2 Europe Anti-Infective Vaccines Sales by Application (2016-2026)

8.3 Europe Anti-Infective Vaccines Market Size by Country

8.3.1 Europe Anti-Infective Vaccines Sales in Volume by Country (2016-2026)

8.3.2 Europe Anti-Infective Vaccines Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Anti-Infective Vaccines Sales by Type (2016-2026)

9.2 Asia-Pacific Anti-Infective Vaccines Sales by Application (2016-2026)

9.3 Asia-Pacific Anti-Infective Vaccines Market Size by Region

9.3.1 Asia-Pacific Anti-Infective Vaccines Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Anti-Infective Vaccines Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Anti-Infective Vaccines Sales by Type (2016-2026)

10.2 South America Anti-Infective Vaccines Sales by Application (2016-2026)

10.3 South America Anti-Infective Vaccines Market Size by Country

10.3.1 South America Anti-Infective Vaccines Sales in Volume by Country (2016-2026)

10.3.2 South America Anti-Infective Vaccines Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Anti-Infective Vaccines Sales by Type (2016-2026)

11.2 Middle East & Africa Anti-Infective Vaccines Sales by Application (2016-2026)

11.3 Middle East & Africa Anti-Infective Vaccines Market Size by Country

11.3.1 Middle East & Africa Anti-Infective Vaccines Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Anti-Infective Vaccines Typical Distributors

12.3 Anti-Infective Vaccines Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Anti-Infective Vaccines Revenue by Type, (USD Million), 2021-2026

Table 2. Global Anti-Infective Vaccines Revenue by Application, (USD Million), 2021-2026

Table 3. Emergent BioDefense Operations Lansing Inc. Basic Information, Manufacturing Base and Competitors

Table 4. Emergent BioDefense Operations Lansing Inc. Major Business

Table 5. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product and Services

Table 6. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table 8. Sanofi Pasteur Major Business

Table 9. Sanofi Pasteur Anti-Infective Vaccines Product and Services

Table 10. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Merck & Co. Basic Information, Manufacturing Base and Competitors

Table 12. Merck & Co. Major Business

Table 13. Merck & Co. Anti-Infective Vaccines Product and Services

Table 14. Merck & Co. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. MedImmune LLC Basic Information, Manufacturing Base and Competitors

Table 16. MedImmune LLC Major Business

Table 17. MedImmune LLC Anti-Infective Vaccines Product and Services

Table 18. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Novartis Vaccines Basic Information, Manufacturing Base and Competitors

Table 20. Novartis Vaccines Major Business

Table 21. Novartis Vaccines Anti-Infective Vaccines Product and Services

Table 22. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Diagnostics Ltd. Basic Information, Manufacturing Base and Competitors

Table 24. Diagnostics Ltd. Major Business

Table 25. Diagnostics Ltd. Anti-Infective Vaccines Product and Services

Table 26. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Intercell Biomedical Basic Information, Manufacturing Base and Competitors

Table 28. Intercell Biomedical Major Business

Table 29. Intercell Biomedical Anti-Infective Vaccines Product and Services

Table 30. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. MassBiologics Basic Information, Manufacturing Base and Competitors

Table 32. MassBiologics Major Business

Table 33. MassBiologics Anti-Infective Vaccines Product and Services

Table 34. MassBiologics Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Barr Labs, Inc. Basic Information, Manufacturing Base and Competitors

Table 36. Barr Labs, Inc. Major Business

Table 37. Barr Labs, Inc. Anti-Infective Vaccines Product and Services

Table 38. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Organon Teknika Co. Basic Information, Manufacturing Base and Competitors

Table 40. Organon Teknika Co. Major Business

Table 41. Organon Teknika Co. Anti-Infective Vaccines Product and Services

Table 42. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. GlaxoSmithKline Biologicals Basic Information, Manufacturing Base and Competitors

Table 44. GlaxoSmithKline Biologicals Major Business

Table 45. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product and Services

Table 46. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. CSL Ltd. Basic Information, Manufacturing Base and Competitors

Table 48. CSL Ltd. Major Business

Table 49. CSL Ltd. Anti-Infective Vaccines Product and Services

Table 50. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. ID Biomedical Co. Basic Information, Manufacturing Base and Competitors

Table 52. ID Biomedical Co. Major Business

Table 53. ID Biomedical Co. Anti-Infective Vaccines Product and Services

Table 54. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Protein Sciences Co. Basic Information, Manufacturing Base and Competitors

Table 56. Protein Sciences Co. Major Business

Table 57. Protein Sciences Co. Anti-Infective Vaccines Product and Services

Table 58. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Wyeth Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 60. Wyeth Pharmaceuticals, Inc. Major Business

Table 61. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product and Services

Table 62. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Berna Biotech Basic Information, Manufacturing Base and Competitors

Table 64. Berna Biotech Major Business

Table 65. Berna Biotech Anti-Infective Vaccines Product and Services

Table 66. Berna Biotech Anti-Infective Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Global Anti-Infective Vaccines Sales by Manufacturer (2019-2021e) & (K Units)

Table 68. Global Anti-Infective Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 69. Market Position of Manufacturers in Anti-Infective Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 70. Global Anti-Infective Vaccines Production Capacity by Company, (K Units): 2020 VS 2021

Table 71. Head Office and Anti-Infective Vaccines Production Site of Key Manufacturer

Table 72. Anti-Infective Vaccines New Entrant and Capacity Expansion Plans

Table 73. Anti-Infective Vaccines Mergers & Acquisitions in the Past Five Years

Table 74. Global Anti-Infective Vaccines Sales by Region (2016-2021e) & (K Units)

Table 75. Global Anti-Infective Vaccines Sales by Region (2021-2026) & (K Units)

Table 76. Global Anti-Infective Vaccines Revenue by Region (2016-2021e) & (USD Million)

Table 77. Global Anti-Infective Vaccines Revenue by Region (2021-2026) & (USD Million)

Table 78. Global Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 79. Global Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 80. Global Anti-Infective Vaccines Revenue by Type (2016-2021e) & (USD Million)

Table 81. Global Anti-Infective Vaccines Revenue by Type (2021-2026) & (USD Million)

Table 82. Global Anti-Infective Vaccines Price by Type (2016-2021e) & (US$/Unit)

Table 83. Global Anti-Infective Vaccines Price by Type (2021-2026) & (US$/Unit)

Table 84. Global Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 85. Global Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 86. Global Anti-Infective Vaccines Revenue by Application (2016-2021e) & (USD Million)

Table 87. Global Anti-Infective Vaccines Revenue by Application (2021-2026) & (USD Million)

Table 88. Global Anti-Infective Vaccines Price by Application (2016-2021e) & (US$/Unit)

Table 89. Global Anti-Infective Vaccines Price by Application (2021-2026) & (US$/Unit)

Table 90. North America Anti-Infective Vaccines Sales by Country (2016-2021e) & (K Units)

Table 91. North America Anti-Infective Vaccines Sales by Country (2021-2026) & (K Units)

Table 92. North America Anti-Infective Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 93. North America Anti-Infective Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 94. North America Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 95. North America Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 96. North America Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 97. North America Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 98. Europe Anti-Infective Vaccines Sales by Country (2016-2021e) & (K Units)

Table 99. Europe Anti-Infective Vaccines Sales by Country (2021-2026) & (K Units)

Table 100. Europe Anti-Infective Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 101. Europe Anti-Infective Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 102. Europe Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 103. Europe Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 104. Europe Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 105. Europe Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 106. Asia-Pacific Anti-Infective Vaccines Sales by Region (2016-2021e) & (K Units)

Table 107. Asia-Pacific Anti-Infective Vaccines Sales by Region (2021-2026) & (K Units)

Table 108. Asia-Pacific Anti-Infective Vaccines Revenue by Region (2016-2021e) & (USD Million)

Table 109. Asia-Pacific Anti-Infective Vaccines Revenue by Region (2021-2026) & (USD Million)

Table 110. Asia-Pacific Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 111. Asia-Pacific Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 112. Asia-Pacific Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 113. Asia-Pacific Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 114. South America Anti-Infective Vaccines Sales by Country (2016-2021e) & (K Units)

Table 115. South America Anti-Infective Vaccines Sales by Country (2021-2026) & (K Units)

Table 116. South America Anti-Infective Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 117. South America Anti-Infective Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 118. South America Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 119. South America Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 120. South America Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 121. South America Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 122. Middle East & Africa Anti-Infective Vaccines Sales by Country (2016-2021e) & (K Units)

Table 123. Middle East & Africa Anti-Infective Vaccines Sales by Country (2021-2026) & (K Units)

Table 124. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 125. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 126. Middle East & Africa Anti-Infective Vaccines Sales by Type (2016-2021e) & (K Units)

Table 127. Middle East & Africa Anti-Infective Vaccines Sales by Type (2021-2026) & (K Units)

Table 128. Middle East & Africa Anti-Infective Vaccines Sales by Application (2016-2021e) & (K Units)

Table 129. Middle East & Africa Anti-Infective Vaccines Sales by Application (2021-2026) & (K Units)

Table 130. Direct Channel Pros & Cons

Table 131. Indirect Channel Pros & Cons

Table 132. Anti-Infective Vaccines Typical Distributors

Table 133. Anti-Infective Vaccines Typical Customers

List of Figures

Figure 1. Anti-Infective Vaccines Picture

Figure 2. Global Anti-Infective Vaccines Sales Market Share by Type in 2020

Figure 3. Inactivated Vaccines

Figure 4. Conjugate Vaccines

Figure 5. Live/attenuated Vaccines

Figure 6. Global Anti-Infective Vaccines Sales Market Share by Application in 2020

Figure 7. Bacterial Diseases

Figure 8. Viral Diseases

Figure 9. Global Anti-Infective Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Anti-Infective Vaccines Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Anti-Infective Vaccines Sales (2016-2026) & (K Units)

Figure 12. Global Anti-Infective Vaccines Price by Type (2016-2026) & (US$/Unit)

Figure 13. Global Anti-Infective Vaccines Production Capacity (2016-2026) & (K Units)

Figure 14. Global Anti-Infective Vaccines Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Anti-Infective Vaccines Market Drivers

Figure 16. Anti-Infective Vaccines Market Restraints

Figure 17. Anti-Infective Vaccines Market Trends

Figure 18. Global Anti-Infective Vaccines Sales Market Share by Manufacturer in 2020

Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Manufacturer in 2020

Figure 20. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Anti-Infective Vaccines Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Anti-Infective Vaccines Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Anti-Infective Vaccines Sales Market Share by Region (2016-2026)

Figure 24. Global Anti-Infective Vaccines Revenue Market Share by Region (2016-2026)

Figure 25. North America Anti-Infective Vaccines Revenue (2016-2026) & (USD Million)

Figure 26. Europe Anti-Infective Vaccines Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Anti-Infective Vaccines Revenue (2016-2026) & (USD Million)

Figure 28. South America Anti-Infective Vaccines Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Anti-Infective Vaccines Revenue (2016-2026) & (USD Million)

Figure 30. Global Anti-Infective Vaccines Sales Market Share by Type (2016-2026)

Figure 31. Global Anti-Infective Vaccines Revenue Market Share by Type (2016-2026)

Figure 32. Global Anti-Infective Vaccines Price by Type (2016-2026) & (US$/Unit)

Figure 33. Global Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 34. Global Anti-Infective Vaccines Revenue Market Share by Application (2016-2026)

Figure 35. Global Anti-Infective Vaccines Price by Application (2016-2026) & (US$/Unit)

Figure 36. North America Anti-Infective Vaccines Sales Market Share by Type (2016-2026)

Figure 37. North America Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 38. North America Anti-Infective Vaccines Sales Market Share by Country (2016-2026)

Figure 39. North America Anti-Infective Vaccines Revenue Market Share by Country (2016-2026)

Figure 40. United States Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Anti-Infective Vaccines Sales Market Share by Type (2016-2026)

Figure 44. Europe Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 45. Europe Anti-Infective Vaccines Sales Market Share by Country (2016-2026)

Figure 46. Europe Anti-Infective Vaccines Revenue Market Share by Country (2016-2026)

Figure 47. Germany Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Anti-Infective Vaccines Revenue Market Share by Region (2016-2026)

Figure 56. China Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Anti-Infective Vaccines Sales Market Share by Type (2016-2026)

Figure 63. South America Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 64. South America Anti-Infective Vaccines Sales Market Share by Country (2016-2026)

Figure 65. South America Anti-Infective Vaccines Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Anti-Infective Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source